Amarantus Bioscience Holdings Inc (AMBS)

[Solantey]

AMBS is the most undervalued bio-tech in the market currently.

If you're reading this post then you know about the tremendous upside that buying at the current share offers to an investor.

Anyone who is on the sidelines waiting for a pullback is going to be sadly disappointed.

There are millions of shares "short" that will have to be bought as the share price continues to climb.

A realistic share price based on currently available information would be in the .20-.25 range with an up trend in place.

Remember that investing in a stock at the bottom is a very good thing and you now have the opportunity to do so.

Exciting months ahead for AMBS shareholders.

The company's management team is "top shelf" and surrounding themselves with some of the best advisors in the bio-tech industry.